Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Among Beneficiaries As Bystolic Antitrust Case Dismissed
Agreements In 2012 And 2013 Alleged To Have Delayed Competition Until 2021
Jan 27 2022
•
By
Dean Rudge
Plaintiffs have a deadline to file an amended complaint • Source: Shutterstock: Chris Bain
More from Legal & IP
More from Generics Bulletin